Baseline and day 90 NIHSS and mRs of patients treated in the field with intravenous rt-PA
| Patient | Age | Sex | NIHSS baseline | NIHSS day 90 | mRs premorbid | mRs day 90 |
| 1 | 63 | F | 2 | 0 | 0 | 1 |
| 2 | 68 | M | 1 | 0 | 0 | 0 |
| 3 | 72 | F | 4 | 0 | 0 | 0 |
| 4 | 34 | M | 10 | 0 | 0 | 0 |
| 5* | 87 | F | 22 | 2 | 6 | |
| 6 | 76 | F | 19 | 4 | 0 | 2 |
| 7† | 81 | F | 4 | 0 | 2 | 2 |
| 8 | 48 | M | 7 | 1 | 0 | 2 |
*This patient presented with large left middle cerebral artery stroke and had ongoing myocardial infarction (non-ST-elevation myocardial infarction). Her premorbid status included prior myocardial infarction, colon cancer and thyroid cancer. The patient’s family decided on end-of-life comfort care right after the patient was transferred to University of Alberta Hospital.
†This patient had oxygen-dependent chronic obstructive pulmonary disease; therefore, her premorbid mRs is 2.
mRs, modified Rankin score; NIHSS, National Institute of Health Stroke Scale; rt-PA, tissue plasminogen activator.